Masimo (MASI) Revenue Growth (5y) (2014 - 2026)
Masimo (MASI) Revenue Growth (5y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.83 Bn | 176.54 Bn | 6.27 Bn |
| 2 | Stryker | 128.96 Bn | 126.08 Bn | 3.81 Bn |
| 3 | Medtronic | 108.62 Bn | 99.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.62 Bn | 67.16 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.35 Bn | 44.67 Bn | 1.29 Bn |
| 6 | Dexcom | 28.45 Bn | 27.33 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.18 Bn | 25.90 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.91 Bn | 26.33 Bn | - |
| 9 | Koninklijke Philips | 24.68 Bn | 21.55 Bn | 2.07 Bn |
| 10 | Masimo | 9.39 Bn | 9.27 Bn | 250.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 4, 2026 | 6.18% |
| Jan 3, 2026 | 6.93% |
| Sep 27, 2025 | 5.96% |
| Jun 28, 2025 | 4.27% |
| Mar 29, 2025 | 6.65% |
| Dec 28, 2024 | 8.28% |
| Sep 28, 2024 | 8.43% |
| Jun 29, 2024 | 8.41% |
| Mar 30, 2024 | 7.95% |
| Dec 30, 2023 | -24.59% |
| Sep 30, 2023 | 17.86% |
| Jul 1, 2023 | 16.56% |
| Apr 1, 2023 | 21.55% |
| Dec 31, 2022 | 27.29% |
| Oct 1, 2022 | 23.22% |
| Jul 2, 2022 | 24.07% |
| Apr 2, 2022 | 9.12% |
| Jan 1, 2022 | 12.33% |
| Oct 2, 2021 | 12.90% |
| Jul 3, 2021 | 12.06% |